| Progenics Pharmaceuticals, Inc. | (NQ: PGNX) |
|
4.810 USD
UNCHANGED
|
| View: | Quote | Chart | Options | News | SEC Filings |
|
Price and Volume
Detailed Quote
Compare to:
|
Top News
More News
Investors eyeing a purchase of Progenics Pharmaceuticals, Inc. (PGNX) stock, but tentative about paying the going market price of $4.70/share, might benefit from considering selling puts among the... Read More
category
Stocks
from Market News Video
|
More News
Read More
Disappointment With BOJ Sends Markets Plunging
June 11, 2013
category
Market News
Bio-Wire Equity Surveillance – Closing Bell 6/11/2013
June 11, 2013
from Bio-Wire.Com
Afternoon Market Losers
June 10, 2013
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here







